atenolol has been researched along with carbamazepine in 59 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.69) | 18.2507 |
| 2000's | 12 (20.34) | 29.6817 |
| 2010's | 33 (55.93) | 24.3611 |
| 2020's | 13 (22.03) | 2.80 |
| Authors | Studies |
|---|---|
| Ax, F; Bonham, NM; Hallberg, A; Karlén, A; Lennernäs, H; Winiwarter, S | 1 |
| Danelian, E; Hämäläinen, MD; Hansson, A; Karlén, A; Karlsson, R; Lennernäs, H; Löfâs, S; Winiwarter, S | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Faller, B; Wohnsland, F | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Bruno-Blanch, L; Gálvez, J; García-Domenech, R | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Conradi, R; Lee, PH; Shanmugasundaram, V | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Avdeef, A; Tam, KY | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Filipek, B; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pańczyk, K; Pękala, E; Rapacz, A; Słoczyńska, K; Waszkielewicz, AM; Żelaszczyk, D; Żesławska, E | 1 |
| Campillo, NE; Cañada, FJ; Canales, A; Carvalho, I; Chierrito, TPC; Martinez, A; Martínez-Gonzalez, L; Pedersoli-Mantoani, S; Perez, C; Pérez, DI; Roca, C; Sebastian-Pérez, V | 1 |
| Bae, MA; Choi, J; Choi, JH; Kim, MJ; Kim, YC; Lee, D; Lee, KR; Lee, S; Park, CJ; Seo, J; Shin, DS; Song, YK | 1 |
| Acevedo, O; Dasararaju, G; Devadasan, V; Halakova, D; Jayaprakash, V; Kovacikova, L; Mohd Siddique, MU; Mondal, SK; Prnova, MS; Shilkar, D; Stefek, M; Thakur, A; Yasmin, S | 1 |
| De Sarro, A; De Sarro, G; Di Paola, ED; Ferreri, G; Fischer, W | 1 |
| Azzoni, A; Raja, M | 1 |
| Adriaensen, J; Augustijns, P; Brewster, ME; Mackie, C; Melis, A; Mensch, J; Noppe, M | 1 |
| Barceló, D; Caminal, G; Marco-Urrea, E; Petrović, M; Radjenović, J; Vicent, T | 1 |
| Lee, Y; von Gunten, U | 1 |
| Alonso, E; Aparicio, I; Bron, JE; Hampel, M; Leaver, MJ; Santos, JL; Taggart, JB | 1 |
| Galceran, MT; Huerta-Fontela, M; Ventura, F | 1 |
| Binelli, A; Parolini, M; Provini, A; Quinn, B | 1 |
| Carriquiriborde, P; Elorriaga, Y; Marino, DJ; Ronco, AE | 1 |
| Jasper, JT; Sedlak, DL | 1 |
| Aceña, J; Barceló, D; Esplugas, S; González, O; Justo, A; Pérez, S; Sans, C | 1 |
| Jeong, CB; Kim, BM; Lee, JS; Lee, YM; Leung, KM; Park, HG; Rhee, JS | 1 |
| Dong, MM; Rosario-Ortiz, FL; Trenholm, R | 1 |
| Bracale, M; Bruno, A; De Mattia, F; Labra, M; Marsoni, M; Vannini, C | 1 |
| Manicke, NE; Zhang, C | 1 |
| Barceló, D; Buttiglieri, G; Diaz-Cruz, MS; Ekowati, Y; Ferrero, G; Kennedy, MD; Petrovic, M; Rodríguez-Roda, I; Valle-Sistac, J; Villagrasa, M | 1 |
| Fér, M; Golovko, O; Grabic, R; Jakšík, O; Klement, A; Kočárek, M; Kodešová, R; Nikodem, A; Vondráčková, L | 1 |
| Golovko, O; Grabic, R; Klement, A; Koba, O; Kodešová, R | 1 |
| Azaïs, A; Brosillon, S; Mendret, J; Petit, E | 1 |
| Baron, MG; Hetheridge, MJ; Jackson, SK; Jha, AN; Mintram, KS; Moody, AJ; Owen, SF; Purcell, WM | 1 |
| Babbucci, M; Bargelloni, L; Blasco, J; Ferraresso, S; Hampel, M; Milan, M | 1 |
| Azaïs, A; Brosillon, S; Cazals, G; Mendret, J; Petit, E | 1 |
| Fér, M; Golovko, O; Grabic, R; Klement, A; Kočárek, M; Kodešová, R; Nikodem, A | 1 |
| Ding, T; Li, J; Wang, S; Yang, B | 1 |
| Beltrán, EM; Fernández Torija, C; González-Doncel, M; Pablos, MV; Porcel, MÁ | 1 |
| Boogaerts, T; Choi, PM; Gao, J; Hollingworth, SA; Jiang, H; O'Brien, JW; Thai, PK; Tscharke, BJ; Yang, M | 1 |
| Battiston, D; Calza, P; Fabbri, D; Marin, ML; Miranda, MA; Pavanello, A | 1 |
| Chang, H; Chen, C; Du, H; Guan, C; Li, C; Qiu, L; Wang, S; Wang, T; Wu, Y; Zhang, L; Zhang, S; Zhou, H | 1 |
| Correia, AT; de Oliveira, TMN; Guimarães, LL; Pisetta, AM; Roveri, V | 1 |
| Erdem, ÇE; Eroğlu, H; Eylem, CC; Gökmen-Özel, H; Ilgaz, F; Nemutlu, E; Timur, SS | 1 |
| Aydın, ME; Aydın, S; Ulvi, A | 1 |
| Correia, AT; Guimarães, LL; Roveri, V; Toma, W | 1 |
| Bai, X; Huang, Z; Li, Q; Lin, X; Zhu, Y | 1 |
| Alonso, E; Aparicio, I; Del Carmen Gómez-Regalado, M; Hidalgo, F; Martín, J; Santos, JL; Zafra-Gómez, A | 1 |
1 review(s) available for atenolol and carbamazepine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
58 other study(ies) available for atenolol and carbamazepine
| Article | Year |
|---|---|
Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.
Topics: Humans; Intestinal Absorption; Jejunum; Models, Biological; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship | 1998 |
SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: correlation with fraction absorbed in humans.
Topics: Humans; Intestinal Absorption; Liposomes; Pharmaceutical Preparations; Pharmacokinetics; Predictive Value of Tests; Surface Plasmon Resonance | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes.
Topics: Alkanes; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Membranes, Artificial; Octanols; Permeability; Pharmaceutical Preparations; Solubility; Water | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship | 2003 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay.
Topics: 1-Methyl-3-isobutylxanthine; Cell Line; Cell Membrane Permeability; Humans; Models, Biological; Quantitative Structure-Activity Relationship; Skin Absorption | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
Topics: Amino Alcohols; Animals; Anticonvulsants; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Mice; Models, Molecular; Molecular Structure; Rats; Seizures; Structure-Activity Relationship | 2017 |
Chameleon-like behavior of indolylpiperidines in complex with cholinesterases targets: Potent butyrylcholinesterase inhibitors.
Topics: Acetylcholinesterase; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Indoles; Molecular Structure; Piperidines; Structure-Activity Relationship | 2018 |
Interplay among Conformation, Intramolecular Hydrogen Bonds, and Chameleonicity in the Membrane Permeability and Cyclophilin A Binding of Macrocyclic Peptide Cyclosporin O Derivatives.
Topics: Animals; Caco-2 Cells; Cell Membrane Permeability; Cyclization; Cyclophilin A; Cyclosporine; Cyclosporins; Drug Design; Humans; Hydrogen Bonding; Male; Mice, Inbred ICR; Molecular Conformation; Protein Binding | 2021 |
Non-carboxylic acid inhibitors of aldose reductase based on N-substituted thiazolidinedione derivatives.
Topics: Aldehyde Reductase; Animals; Caco-2 Cells; Catalytic Domain; Dogs; Enzyme Inhibitors; Humans; Hypoglycemic Agents; Madin Darby Canine Kidney Cells; Male; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Protein Binding; Rats, Wistar; Structure-Activity Relationship; Thiazolidinediones | 2021 |
Influence of some beta-adrenoceptor antagonists on the anticonvulsant potency of antiepileptic drugs against audiogenic seizures in DBA/2 mice.
Topics: Acoustic Stimulation; Adrenergic beta-Antagonists; Animals; Anticonvulsants; Atenolol; Body Temperature; Carbamazepine; Epilepsy, Reflex; Female; Lamotrigine; Male; Metoprolol; Mice; Mice, Inbred DBA; Motor Activity; Phenobarbital; Propanolamines; Propranolol; Stereoisomerism; Triazines; Valproic Acid | 2002 |
Oxcarbazepine, risperidone and atenolol overdose with benign outcome.
Topics: Adrenergic beta-Antagonists; Adult; Alcoholism; Anticonvulsants; Antipsychotic Agents; Atenolol; Bipolar Disorder; Carbamazepine; Cocaine-Related Disorders; Drug Overdose; Humans; Male; Oxcarbazepine; Risperidone | 2003 |
Novel generic UPLC/MS/MS method for high throughput analysis applied to permeability assessment in early Drug Discovery.
Topics: Ampicillin; Atenolol; Caffeine; Carbamazepine; Chromatography, High Pressure Liquid; Griseofulvin; Permeability; Pharmaceutical Preparations; Propranolol; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2007 |
Oxidation of atenolol, propranolol, carbamazepine and clofibric acid by a biological Fenton-like system mediated by the white-rot fungus Trametes versicolor.
Topics: Atenolol; Benzoquinones; Biodegradation, Environmental; Carbamazepine; Clofibric Acid; Hydrogen Peroxide; Iron; Oxalates; Oxidation-Reduction; Pharmaceutical Preparations; Propranolol; Trametes; Waste Disposal, Fluid; Water Pollutants, Chemical | 2010 |
Oxidative transformation of micropollutants during municipal wastewater treatment: comparison of kinetic aspects of selective (chlorine, chlorine dioxide, ferrate VI, and ozone) and non-selective oxidants (hydroxyl radical).
Topics: Ammonia; Atenolol; Bromides; Carbamazepine; Chlorine; Chlorine Compounds; Efficiency; Ethinyl Estradiol; Fresh Water; Hydroxyl Radical; Ibuprofen; Iron; Kinetics; Nitrites; Organic Chemicals; Oxidants; Oxidation-Reduction; Oxides; Ozone; Sulfamethoxazole; Waste Disposal, Fluid; Water Pollutants, Chemical | 2010 |
Potential physiological effects of pharmaceutical compounds in Atlantic salmon (Salmo salar) implied by transcriptomic analysis.
Topics: Acetaminophen; Animals; Atenolol; Carbamazepine; Environmental Monitoring; Fish Proteins; Gene Expression; Gene Expression Profiling; Male; RNA, Messenger; Salmo salar; Water Pollutants, Chemical | 2010 |
Occurrence and removal of pharmaceuticals and hormones through drinking water treatment.
Topics: Atenolol; Carbamazepine; Hormones; Hydrochlorothiazide; Ozone; Pharmaceutical Preparations; Phenytoin; Sotalol; Water Pollutants, Chemical; Water Purification; Water Supply | 2011 |
Cytotoxicity assessment of four pharmaceutical compounds on the zebra mussel (Dreissena polymorpha) haemocytes, gill and digestive gland primary cell cultures.
Topics: Animals; Atenolol; Carbamazepine; Cells, Cultured; Diclofenac; Digestive System; Dreissena; Gemfibrozil; Gills; Hemocytes; Prescription Drugs; Water Pollutants, Chemical | 2011 |
Human pharmaceuticals in wastewaters from urbanized areas of Argentina.
Topics: Argentina; Atenolol; Caffeine; Carbamazepine; Chromatography, High Pressure Liquid; Cities; Diclofenac; Environmental Monitoring; Humans; Ibuprofen; Mass Spectrometry; Pharmaceutical Preparations; Wastewater; Water Pollutants, Chemical | 2013 |
Phototransformation of wastewater-derived trace organic contaminants in open-water unit process treatment wetlands.
Topics: Atenolol; Carbamazepine; Carbonates; Cimetidine; Dimethylnitrosamine; Diuron; Estradiol; Hydroxyl Radical; Models, Chemical; Photolysis; Propranolol; Sulfamethoxazole; Sunlight; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Wetlands | 2013 |
Pharmaceuticals and organic pollution mitigation in reclamation osmosis brines by UV/H2O2 and ozone.
Topics: Atenolol; Carbamazepine; Filtration; Hydrogen Peroxide; Hydrogen-Ion Concentration; Kinetics; Osmosis; Oxygen; Ozone; Paroxetine; Pharmaceutical Preparations; Salts; Trimethoprim; Ultraviolet Rays; Waste Disposal, Fluid; Wastewater; Water; Water Pollutants, Chemical; Water Purification | 2013 |
Effect of pharmaceuticals exposure on acetylcholinesterase (AchE) activity and on the expression of AchE gene in the monogonont rotifer, Brachionus koreanus.
Topics: Acetaminophen; Acetylcholinesterase; Amino Acid Sequence; Analgesics, Non-Narcotic; Animals; Anti-Bacterial Agents; Atenolol; Base Sequence; Biocatalysis; Carbamazepine; Chlorpyrifos; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Helminth Proteins; Molecular Sequence Data; Oxytetracycline; Reverse Transcriptase Polymerase Chain Reaction; Rotifera; Sulfamethoxazole; Time Factors; Trimethoprim; Water Pollutants, Chemical; Xenobiotics | 2013 |
Photochemical degradation of atenolol, carbamazepine, meprobamate, phenytoin and primidone in wastewater effluents.
Topics: Atenolol; Carbamazepine; Hydroxyl Radical; Meprobamate; Oxidants; Phenytoin; Photolysis; Primidone; Singlet Oxygen; Sunlight; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical | 2015 |
Uptake and effects of a mixture of widely used therapeutic drugs in Eruca sativa L. and Zea mays L. plants.
Topics: Albuterol; Atenolol; Bezafibrate; Brassicaceae; Carbamazepine; Cyclophosphamide; Drug Interactions; Germination; Humans; Lincomycin; Ofloxacin; Pharmaceutical Preparations; Ranitidine; Rivers; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical; Zea mays | 2014 |
Development of a Paper Spray Mass Spectrometry Cartridge with Integrated Solid Phase Extraction for Bioanalysis.
Topics: Alprazolam; Animals; Atenolol; Carbamazepine; Cattle; Diazepam; Mass Spectrometry; Paper; Solid Phase Extraction; Sulfamethazine | 2015 |
Occurrence of pharmaceuticals and UV filters in swimming pools and spas.
Topics: Atenolol; Baths; Carbamazepine; Chromatography, High Pressure Liquid; Solid Phase Extraction; Swimming Pools; Tandem Mass Spectrometry; Ultraviolet Rays; Water Pollutants, Chemical; Water Purification | 2016 |
Simultaneous sorption of four ionizable pharmaceuticals in different horizons of three soil types.
Topics: Adsorption; Atenolol; Carbamazepine; Ions; Pharmaceutical Preparations; Soil; Soil Pollutants; Sulfamethoxazole; Trimethoprim | 2016 |
Transformation of atenolol, metoprolol, and carbamazepine in soils: The identification, quantification, and stability of the transformation products and further implications for the environment.
Topics: Atenolol; Carbamazepine; Groundwater; Humans; Metoprolol; Soil; Soil Pollutants | 2016 |
Influence of volumetric reduction factor during ozonation of nanofiltration concentrates for wastewater reuse.
Topics: Acetaminophen; Atenolol; Carbamazepine; Diatrizoate; Filtration; Nanotechnology; Oxidants; Oxidation-Reduction; Ozone; Recycling; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Water Purification | 2016 |
Pharmaceutical Metabolism in Fish: Using a 3-D Hepatic In Vitro Model to Assess Clearance.
Topics: Animals; Atenolol; Biotransformation; Carbamazepine; Diazepam; Diclofenac; Drug Evaluation, Preclinical; Female; Kinetics; Liver; Metoprolol; Models, Animal; Oncorhynchus mykiss; Phenylbutazone; Propranolol; Tandem Mass Spectrometry; Water Pollutants, Chemical; Xenobiotics | 2017 |
Transcriptome analysis of the brain of the sea bream (Sparus aurata) after exposure to human pharmaceuticals at realistic environmental concentrations.
Topics: Acetaminophen; Animals; Atenolol; Biomarkers; Brain; Carbamazepine; Fish Proteins; Gene Expression Profiling; Pharmaceutical Preparations; Sea Bream; Transcriptome; Water Pollutants, Chemical | 2017 |
Ozonation as a pretreatment process for nanofiltration brines: Monitoring of transformation products and toxicity evaluation.
Topics: Acetaminophen; Atenolol; Carbamazepine; Chromatography, Liquid; Filtration; Membranes, Artificial; Nanotechnology; Osmosis; Ozone; Salts; Tandem Mass Spectrometry; Toxicity Tests, Acute; Wastewater; Water Pollutants, Chemical; Water Purification | 2017 |
Root uptake of atenolol, sulfamethoxazole and carbamazepine, and their transformation in three soils and four plants.
Topics: Atenolol; Carbamazepine; Plant Leaves; Plants; Raphanus; Soil; Soil Pollutants; Sulfamethoxazole | 2019 |
Biological removal of pharmaceuticals by Navicula sp. and biotransformation of bezafibrate.
Topics: Atenolol; Bezafibrate; Biodegradation, Environmental; Carbamazepine; Diatoms; Fresh Water; Ibuprofen; Inactivation, Metabolic; Naproxen; Pharmaceutical Preparations; Sulfamethoxazole; Water Pollutants, Chemical | 2020 |
Uptake of atenolol, carbamazepine and triclosan by crops irrigated with reclaimed water in a Mediterranean scenario.
Topics: Agricultural Irrigation; Atenolol; Carbamazepine; Crops, Agricultural; Humans; Spain; Triclosan; Wastewater; Water Pollutants, Chemical | 2020 |
Using Prescription and Wastewater Data to Estimate the Correction Factors of Atenolol, Carbamazepine, and Naproxen for Wastewater-Based Epidemiology Applications.
Topics: Atenolol; Australia; Carbamazepine; Naproxen; Prescriptions; Wastewater; Wastewater-Based Epidemiological Monitoring; Water Pollutants, Chemical | 2021 |
Photocatalytic degradation of drugs in water mediated by acetylated riboflavin and visible light: A mechanistic study.
Topics: Acetylation; Atenolol; Carbamazepine; Catalysis; Kinetics; Light; Photolysis; Riboflavin; Singlet Oxygen; Water Pollutants, Chemical | 2021 |
Effects of membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver of drugs: A microdialysis study in rats.
Topics: Animals; Antipyrine; Atenolol; Carbamazepine; Cell Membrane; Digoxin; Diltiazem; Diphenhydramine; Drug Elimination Routes; Gabapentin; Lamotrigine; Liver; Memantine; Membrane Transport Proteins; Microdialysis; Muscle, Skeletal; Ofloxacin; Pharmaceutical Preparations; Propranolol; Pyrilamine; Quinidine; Rats; Terfenadine | 2021 |
First report on the occurrence of pharmaceuticals and cocaine in the coastal waters of Santa Catarina, Brazil, and its related ecological risk assessment.
Topics: Acetaminophen; Atenolol; Brazil; Caffeine; Carbamazepine; Chromatography, Liquid; Cocaine; Cosmetics; Diclofenac; Ecosystem; Environmental Monitoring; Humans; Losartan; Orphenadrine; Pharmaceutical Preparations; Risk Assessment; Sewage; Solid Waste; Tandem Mass Spectrometry; Water; Water Pollutants, Chemical | 2022 |
Do Thickening Agents Used in Dysphagia Diet Affect Drug Bioavailability?
Topics: Animals; Atenolol; Biological Availability; Carbamazepine; Cefixime; Chromatography, Liquid; Deglutition Disorders; Diet; Food Additives; Humans; Levetiracetam; Plant Nectar; Rabbits; Starch; Tablets; Tandem Mass Spectrometry; Viscosity; Water | 2022 |
Fate of selected pharmaceuticals in hospital and municipal wastewater effluent: occurrence, removal, and environmental risk assessment.
Topics: Atenolol; Carbamazepine; COVID-19; Environmental Monitoring; Hospitals; Humans; Lipids; Pandemics; Pharmaceutical Preparations; Risk Assessment; Sewage; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical | 2022 |
Occurrence, ecological risk assessment and prioritization of pharmaceuticals and abuse drugs in estuarine waters along the São Paulo coast, Brazil.
Topics: Acetaminophen; Atenolol; Brazil; Caffeine; Carbamazepine; Chromatography, Liquid; Cocaine; Diclofenac; Ecosystem; Environmental Monitoring; Furosemide; Illicit Drugs; Losartan; Orphenadrine; Pharmaceutical Preparations; Risk Assessment; Rivers; Tandem Mass Spectrometry; Water Pollutants, Chemical | 2022 |
A super-hydrophilic partially reduced graphene oxide membrane with improved stability and antibacterial properties.
Topics: Amlodipine; Anti-Bacterial Agents; Atenolol; Calcium Chloride; Carbamazepine; Chlorides; Graphite; Hydrophobic and Hydrophilic Interactions; Ibuprofen; Membranes, Artificial; Pharmaceutical Preparations; Piperazines; Polyphenols; Salts; Sodium Chloride; Tea; Water | 2022 |
Bioconcentration of pharmaceuticals in benthic marine organisms (Holothuria tubulosa, Anemonia sulcata and Actinia equina) exposed to environmental contamination by atenolol and carbamazepine.
Topics: Animals; Aquatic Organisms; Atenolol; Bioaccumulation; Carbamazepine; Holothuria; Pharmaceutical Preparations; Water Pollutants, Chemical | 2023 |